Detalles de la búsqueda
1.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(7): 919-930, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35690073
2.
Assessing the Quality of Care Delivered to Transgender and Gender Diverse Patients with Cancer in Ireland: A Case Series.
Oncologist
; 26(4): e603-e607, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33252154
3.
Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial.
Lancet Oncol
; 21(7): 969-977, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32615110
4.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
Lancet
; 394(10214): 2084-2095, 2019 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31791688
5.
Prevalence of Insomnia in an Oncology Patient Population: An Irish Tertiary Referral Center Experience.
J Natl Compr Canc Netw
; 18(12): 1623-1630, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33285516
6.
The use of eHealth to promote physical activity in cancer survivors: a systematic review.
Support Care Cancer
; 26(10): 3323-3336, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29909476
7.
Rucaparib for BRCA1/2-mutated pretreated ovarian cancer: reflections from the ARIEL4 trial.
Lancet Oncol
; 23(4): 440-441, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35298905
8.
Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer.
Eur Respir J
; 46(6): 1762-72, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26541534
9.
Patient knowledge, personal experience, and impact of the first wave of the COVD-19 pandemic in an Irish oncology cohort.
Ir J Med Sci
; 192(2): 533-540, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35411487
10.
Feasibility and preliminary efficacy of a physiotherapy-led remotely delivered physical activity intervention in cancer survivors using wearable technology. The IMPETUS trial.
Physiother Theory Pract
; : 1-12, 2022 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36424873
11.
Circulating Tumour Cell Numbers Correlate with Platelet Count and Circulating Lymphocyte Subsets in Men with Advanced Prostate Cancer: Data from the ExPeCT Clinical Trial (CTRIAL-IE 15-21).
Cancers (Basel)
; 13(18)2021 Sep 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34572916
12.
Oral rivaroxaban for pulmonary embolism.
N Engl J Med
; 366(26): 2525; author reply 2526-7, 2012 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-22738105
13.
OK432-activated human dendritic cells kill tumor cells via CD40/CD40 ligand interactions.
J Immunol
; 181(5): 3108-15, 2008 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18713981
14.
Perceptions of eHealth-Enabled Physical Activity Interventions Among Cancer Survivors: Mixed Methods Study.
JMIR Cancer
; 6(1): e16469, 2020 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32343259
15.
Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials Ireland.
Cancers (Basel)
; 12(7)2020 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32708702
16.
eHealth-based intervention to increase physical activity levels in people with cancer: protocol of a feasibility trial in an Irish acute hospital setting.
BMJ Open
; 9(3): e024999, 2019 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30852540
17.
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?
Front Endocrinol (Lausanne)
; 10: 89, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30863365
18.
The ExPeCT (Examining Exercise, Prostate Cancer and Circulating Tumour Cells) trial: study protocol for a randomised controlled trial.
Trials
; 18(1): 456, 2017 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28978344
19.
A novel serum microRNA panel to discriminate benign from malignant ovarian disease.
Cancer Lett
; 356(2 Pt B): 628-36, 2015 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-25451316
20.
Patients over 65 years are assigned lower ECOG PS scores than younger patients, although objectively measured physical activity is no different.
J Geriatr Oncol
; 5(1): 49-56, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24484718